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A 96-well solid-phase extraction (SPE) system is used to rapidly prepare human urine samples
for high-throughput quantitative analysis of two steroids, equilenin and progesterone, by
liquid chromatography-tandem mass spectrometry using deuterated estrone as the internal
standard. We define high-throughput here as analysis of 384 samples in a 24 h period. A total
of 384 samples and standards were extracted by an individual in one day and subsequently
analyzed within a 24 h period. The inter- and intratray accuracy and precision obtained over
the course of these injections was within 8% coefficient of variation when analyzed by
atmospheric pressure chemical ionization mass spectrometry using positive ion detection. A
semiautomated sample processing workstation was used to add internal standard and then
process 96 samples at a time. The recovery of the analytes from the SPE was approximately
85%. The accuracy and precision obtained was comparable to that ordinarily obtained using
manual sample preparation techniques. (J Am Soc Mass Spectrom 1999, 10,
1322–1327) © 1999 American Society for Mass Spectrometry
New techniques in synthetic organic chemistryhave created the ability to synthesize largelibraries of compounds for biological activity
screening. Many high-throughput techniques and
screening assays have been developed and automated
to expedite lead candidate selection in drug discovery
[1]. This capability has led to an even greater need for
rapid toxicological and pharmacokinetic evaluation of
lead drug candidates and, consequently, for rapid sam-
ple preparation and analysis. Two developments that
have aided in rapid sample preparation and analysis
are the 96-well format for solid-phase extraction (SPE)
and atmospheric pressure ionization-tandem mass
spectrometry. Although the 96-well format has been
utilized for many years for immunoassays and in vitro
receptor binding studies, its use for SPE is relatively
new [2,3]. The ability to rapidly process large numbers
of samples in an automated fashion can shift the anal-
ysis bottleneck from sample preparation to analysis
itself. High-throughput liquid chromatography-tandem
mass spectrometry (LC/MS/MS) analyses can accom-
modate short chromatographic runs at the expense of
good chromatographic separation. Because the quality
of analytical results are tantamount to speed, sacrifices
in chromatographic separation must also accommodate
situations where drug metabolites or sample matrix
interfere with the accurate determination of analytes
[4]. In many cases, however, after identification of major
metabolites, the selectivity of tandem mass spectrome-
try will allow the use of much shorter chromatographic
run times.
To determine what the current limitations are with
regard to high-throughput sample preparation and
LC/MS/MS analysis, we chose to evaluate semiauto-
mated robotic sample preparation in the 96-well format.
One goal was to determine the accuracy and precision
values that could be obtained using 96-well SPE when
analyses are performed with large numbers of biologi-
cal samples and over a continuous 24 h period. It was
also of interest to determine if other problems might
arise when performing hundreds of analyses in a rela-
tively short period of time. To test this, samples were
extracted in four 96-well blocks, each containing stan-
dards and QC samples. The results were compiled both
as individual “runs,” or blocks, and as one large run of
384 samples. The samples were prepared and analyzed
in a fashion that would comply with commonly ac-
cepted good laboratory practices (GLP) criteria used in
validation of bioanalytical methods.
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Steroids were chosen which are found in females due
to an interest in estrogens and their known influence on
breast cancer risk in women [5,6]. An increase in breast
cancer risk has been associated with higher lifetime
exposure to estrogens [7]. At the same time, estrogen
replacement therapy (ERT) has a long history of use in
the United States for the treatment of postmenopausal
symptoms and is showing additional benefits in re-
duced incidence of heart disease and osteoporosis [8].
Because there may be an increased need for analyzing
large numbers of female urine samples for estrogen
monitoring in the future, the described strategy was
undertaken to possibly serve this potential need.
Experimental
Chemicals
Steroid standards (progesterone, equilenin, 16 hy-
droxyestrone) were purchased from Steraloids (Wilton,
NH) and 2,4,16,16 d4-estrone from C/D/N Isotopes
(Pointe Claire, Canada). Solvents were obtained from
Mallinkrodt Baker (Phillipsburg, NJ) and water col-
lected fresh from a Barnstead (Dubuque, IA) Nanopure
water purification system. Formic acid, 88% double
distilled, was obtained from GFS Chemicals (Columbus,
OH).
Preparation of Standards
Standard solutions were made at a concentration of
approximately 1 mg/mL in ethanol. Separate weigh-
ings of each compound were used for the quality
control standards (QCs) and the calibration standards
(CSs). The internal standard, d4-estrone, was then fur-
ther diluted with water, to a concentration of 625
ng/mL, for addition to each sample. For each block of
96 wells, CSs were placed at the beginning and end by
spiking 500 mL of blank male urine with 10 mL of an
appropriate ethanol-diluted standard solution. Urine
CSs were prepared to give concentration levels of 0, 1, 3,
10, 30, 100, 300, and 1000 ng/mL. QCs were prepared in
the same fashion at levels of 8, 50, and 500 ng/mL with
six replicates being interspersed among samples, and
between each CSs series. The same female pregnancy
urines were used as samples for each of the four 96-well
blocks.
The 96-well SPE blocks were obtained from 3M
Corporation (St. Paul, MN). Polypropylene deep-well
blocks were obtained from Chrom Tech. (Apple Valley,
MN). The HPLC system used was comprised of two
Shimadzu 10AD pumps, an SCL-10A System controller,
and a SIL-10A autoinjector upgraded with an MTP-96
ROM chip (Shimadzu Scientific Instruments, Columbia,
MD). The latter allows injections to be made directly
from a 96-well microtiter plate on the SIL-10A autoin-
jector. The column used was a Keystone Scientific
(Bellefonte, PA) Javelin guard column (2 mm i.d. 3 20
mm) packed with Betasil C8, 5 mm particles. Solvent A
was a solution of 10% methanol in water, whereas
solvent B was 90% methanol in water. Both solvent
mixtures had formic acid added to a final concentration
of 0.05% by volume. Isocratic conditions of 65% B, 35%
A were used at a flow rate of 400 mL/min.
A Waters (Milford, MA) pneumatically actuated
switching valve was used to direct column effluent
away from the mass spectrometer during the first 0.65
min of each run and before the analytes of interest
eluted. Timing of these events was controlled using the
Shimadzu system controller.
Mass Spectrometry
All analyses were performed on a PE Sciex (Concord,
ON) API 300 tandem mass spectrometer operated in the
atmospheric pressure chemical ionization (APCI) mode
with positive ion detection. The heated pneumatic neb-
ulizer was operated at a temperature of 480 °C using a
nitrogen gas flow of 2.5 L/min. The mass spectrometer
was calibrated using a 10 mM solution of PPG 425 to
obtain peak widths of 0.7 u, or less, in both Q1 and Q3
across the mass range of 60 to 800 Da. Additional tuning
and optimization of the instrument was performed by
infusion of the analytes into the LC mobile phase to
obtain optimum settings and sprayer positioning for the
selected mass transitions. For all MS/MS experiments
the collision gas pressure was set at position “2” on the
PE-SCIEX API 300 system while the collision energy
was set at 25 V. Data was processed using MacQuan
version 1.5 software. For each analyte the protonated
molecule served as the precursor ion. A single precur-
sor ion–product ion transition was monitored for each
analyte as follows; equilenin, m/z 267 to m/z 209; d4-
estrone, m/z 275 to m/z 135; progesterone, m/z 315 to m/z
97. In order to keep scan rates high the internal stan-
dard and equilenin were monitored in an initial period
using 200 ms dwell times, whereas progesterone was
monitored in a second period using a dwell time of 300
ms.
Semiautomated Sample Processing
A Tomtec Quadra 96 Model 320 was used to prepare
urine sample extracts in the 96-well format. Deep-well
(1 mL/well) microtiter blocks of 96 samples were pre-
pared in the following fashion. First, an accurate 500 mL
aliquot of either sample, standard, or QC sample, was
placed in appropriate wells of a deep-well block. The
block was placed at one station of the instrument and a
new set of 96 polypropylene tips was loaded onto the
instrument. A new C8 Empore 96-well SPE block was
placed on the vacuum manifold and conditioned with
200 mL of methanol followed by 200 mL of water.
Immediately after aspiration of the water the vacuum
was turned off and the same tips were used to aspirate
400 mL of water containing the d4-estrone internal
standard (IS) and dispense it into the block containing
the samples. This was followed by a three cycle aspirate
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and dispense step to mix IS and sample. Two separate
425 mL aliquots of the resulting solution were applied to
the 96-well SPE block and subsequently aspirated
through by vacuum. At this point a new set of tips was
placed on the 96-well head and three 375 mL aliquots of
water were dispensed into each well as a washing step,
and aspirated through together. This step was per-
formed twice to give a total water wash volume of over
2 mL. This was followed by a 200 mL wash with 40%
methanol in water. The waste collection dish was re-
placed with a deep-well polypropylene collection block
and a single elution with 100 mL of acetonitrile per-
formed. Finally, the 96-well SPE block was removed
and 400 mL of 0.2% formic acid in water was added to
each well using the same set of tips to give a solution of
the analyte in 20% acetonitrile. The collection block was
then sealed with a piece of 3M adhesive tape supplied
with the SPE blocks, and inserted into the autoinjector.
Results and Discussion
One goal of this work was to develop an analytical
strategy for the determination of representative neutral
steroidal compounds in urine samples. Our previous
work with both corticosteroids [9] and anabolic steroids
[10] has highlighted the challenges of identifying and
quantifying this class of compounds at trace levels in
biological samples. We [11] and others [12] continue to
be challenged by the relatively dirty biological extracts
when isolating important test articles from biological
samples for high-throughput LC/MS/MS applications.
Clearly there is a need for improved procedures for
characterizing this important group of neutral com-
pounds. Recent studies from van Berkel et al. [13] have
employed chemical derivatizations to enhance the de-
tectability of steroidal compounds, while we and others
have employed negative ion detection [14] and counte-
rion attachment [15] to enhance the LC/MS sensitivity
for neutral chemical entities.
A second goal was to determine how 96-well sample
extraction can serve in today’s analytical laboratory
where high-throughput sample analysis is in demand.
There is a growing need to improve sample preparation
throughput for analysis of larger numbers of samples in
shorter periods of time. Pharmaceutical drug develop-
ment and drug discovery studies are also requiring
more rapid turnaround of analytical results so that
subsequent dosing studies can be undertaken. This
paper presents a study into the use of multiple 96-well
plates, equipped with the Empore disk SPE technology,
for parallel sample preparation and subsequent LC/
MS/MS analysis of 384 samples in a 24 h period.
Two important steroids were selected for these stud-
ies; equilenin, an important component of estrogen
replacement therapy, and progesterone, a major steroid
component of human pregnancy urine. The product ion
mass spectra of these steroids are shown in Figure 1
along with their structures.
In preliminary work it was determined that the best
APCI sensitivity was obtained using 0.1% formic acid in
the mobile phase, with the protonated molecule ion
selected as the precursor ion. An optimized SPE extrac-
tion method for several steroids was reported previ-
ously [16]. Essentially, extraction optimization showed
that (1) 200 mL of 30% methanol in water could be used
as a washing step following a water wash, (2) a single
100 mL elution with acetonitrile was sufficient to re-
cover 85% of each analyte, and (3) while urine pH had
Figure 1. Collision-induced dissociation product ion mass spec-
tra and structures of progesterone, equilenin, and d4-estrone.
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no influence on recovery of analyte it did have a
significant influence on retention of unwanted urine
components as determined by HPLC with UV detection
(220 nm). Decreasing the urine pH from 8 to 2, by
adjustment with dilute formic acid prior to SPE,
showed increasing amounts of early eluting urine con-
taminants. In separate experiments the influence of the
percentage of organic solvent in the sample solution
was evaluated with regard to peak shape. Up to 30%
acetonitrile in water gave reasonable chromatographic
peak shape while at 40% acetonitrile the peak heights
were sharply reduced and peaks broadened. To elimi-
nate a sample blowdown step larger injection volumes
(200 mL) of sample were used with a conservative
percentage of organic solvent (20% acetonitrile in wa-
ter) which affected sample focusing on the head of the
reversed-phase HPLC column.
A calibration curve for equilenin and progesterone,
generated over the 23.5 h analysis time period, is shown
in Figure 2. Including each of the eight calibration data
points in the fit, correlation coefficients of 0.995, or
better, were obtained for the two analytes. For equile-
nin, only three points out of 56 were excluded from the
calibration curve while another one deviated by more
than 20% from the expected concentration. For proges-
terone, three points were excluded with one additional
point deviating by more than 20%. Using the calibration
standards at the beginning and end of the analysis, e.g.,
standard sets one and eight separated by 23 h in time,
also provided correlation coefficients of sufficiently
good fit (0.993 or better) to quantify the samples and
QCs. In this case, two points were excluded from the
regression (out of 14 total) for equilenin with another
two points having deviations of greater than 15%. For
progesterone, just one point was excluded with another
single point having a deviation of more than 10%. In no
case were both points at a single concentration ex-
cluded. The agreement seen between CSs analyzed at
the beginning and end of the 384 sample run demon-
strates the feasibility of performing large analytical runs
with standards placed at the beginning and end of the
run only. However, in those instances where the devel-
oped method is not sufficiently robust to provide reli-
able performance, it may be recommended to use two
sets of standard samples in each 96-well plate. In these
latter situations if a subsequent plate fails to meet
acceptance criteria, it may be that the analytical deter-
minations from the earlier samples may not be lost.
Accuracy values for equilenin and progesterone QC
samples are shown in Table 1 for results generated by
use of the two extreme calibration standard series and
with all eight calibration series. One result of using only
two calibration curves is a slight increase in the devia-
tion of the QCs for equilenin. Upon examination it was
observed that the first calibration series was somewhat
higher in value than the other points of the curve. By
inclusion of all eight points the regression is placed
more accurately across the points and this is reflected in
the lower deviation of the QCs. For progesterone, the
deviations had only minor differences between the use
of two and eight calibration series.
The results of an analysis of variance (ANOVA) [17]
for each analyte, from calculations generated by use of
two calibration series, is shown in Table 2. For all QC
levels, and for both analytes, there was found to be a
significant contribution to the overall variance, at a
confidence level of } 5 0.05, as a result of performing
the extraction in separate blocks of 96. Thus, despite the
fact that all four blocks were prepared by a single
Figure 2. Calibration curves created for equilenin and progester-
one extracted from urine using eight replicates at each concentra-
tion level and analyzed over a 23.5 h period.
Table 1. Accuracy of QC determinations using either two or
eight replicates at each standard concentrationa
QC1
(8 ng/mL)
QC2
(50 ng/mL)
QC3
(500 ng/mL)
(A) Equilenin
Two standard series 92.2 95.6 94.5
Eight standard series 93.4 98.3 97.3
(B) Progesterone
Two standard series 93.2 95.4 102.5
Eight standard series 94.7 95.4 102.3
aAccuracy is calculated as [1 2 (calculated mean/theoretical value)] 3
100.
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analyst and analyzed within 24 h, there are additional
influences that could be examined in an attempt to
achieve lower interassay variability. However, the co-
efficient of variation (both inter- and intra-assay preci-
sion) is seen to be less than 8% in all cases.
Representative chromatograms for a control blank
urine followed by QC samples spiked with (A) equile-
nin and (B) progesterone, at the beginning, middle, and
end of the entire analytical run (384 samples) are shown
in Figure 3. Retention time, peak intensity, and peak
shape reproducibility are seen to be excellent over the
course of the entire run. Although some increase in the
column pressure was noted over the course of the
analytical run, it was not sufficient to cause system
failure and could be alleviated by replacement of the frit
filter at the beginning of each day or by replacement of
the relatively inexpensive analytical, “guard” column
altogether.
Conclusions
The purpose of this work was to determine what the
current practical limitations are to performing high-
throughput sample preparation and LC/MS/MS anal-
ysis. For the purposes of this work we define high-
throughput as 384 samples prepared and then analyzed
within a 24 h period. To evaluate high-throughput
sample processing capabilities the 96-well SPE blocks
were used in a semiautomated instrument designed to
aspirate and dispense solutions using 96 tips at a time.
This is in contrast to other types of automated sample
processors which prepare four, or eight, samples at a
time. Although there are several robotic instruments
which provide excellent liquid handling, and which
perform extractions without operator attendance, the
system used in this work does require operator atten-
dance to control vacuum application to the SPE mani-
fold.
Although there are advantages to increasing the
analytical run size there are also risks. For example, in
some percentage of analytical runs we might find that
the last series of CSs may not produce a sufficiently
good fit to quantify the data. In such a case it is of
benefit to have multiple calibration curves in each
96-well plate and to use all those which are acceptable
up to the point that a failure occurs. The authors are
currently evaluating options for decreasing the number
of calibration series used in large analytical runs. The
benefits of reducing the number of curves per analytical
run must be carefully balanced with the risk of the run
failing and the consequence of having to repeat the
entire run.
An approach has been described for significantly
increasing sample preparation and analysis throughput
by LC/MS/MS using an APCI source. The results
shown demonstrate the level of throughput achievable
when chromatographic conditions allow the use of
short analysis times.
Table 2. Results from one-way analysis of variance (ANOVA)a
Intra-assay
precision
Inter-assay
precision p value Fcalc
Equilenin
QC1 (8 ng/mL) 6.02% 3.94% 0.0323 4.26
QC2 (50 ng/mL) 3.43% 4.28% 0.0003 3.41
QC3 (500 ng/mL) 2.81% 3.69% 0.0001 7.37
Progesterone
QC1 (8 ng/mL) 7.98% 5.88% 0.0176 3.57
QC2 (50 ng/mL) 6.24% 3.95% 0.0375 10.36
QC3 (500 ng/mL) 6.33% 6.52% 0.0016 11.34
aF critical0.05,3,20 5 3.1.
Figure 3. Representative chromatograms of a control blank (Well
#23) and of the low QC for (A) equilenin and (B) progesterone at
the beginning (Well #17), middle (Well #174), and end (Well #366)
of the 384 sample run.
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